Association between baseline absolute neutrophil count (ANC), derived neutrophil-to-lymphocyte ratio (dNLR), and platelet-to-lymphocyte ratio (PLR) and response to nivolumab (Nivo) in non-small cell lung cancer (NSCLC): A preliminary analysis.
2017-01-01 Russo, A; Scimone, A; Picciotto, M; Toscano, G; Raiti, F; Sava, S; Battaglia, A; Adamo, V.
Epidermal Growth Factor Receptor mutational status predicts patterns of metastatic spread in treatment-naïve Adenocarcinomas of the lung.
2015-01-01 Russo, A; Franchina, T; Picone, A; Raiti, F; Ricciardi, Grr; Franchina, V; Ferraro, G; Scimone, A; Toscano, G; Adamo, V.
Application of ESCAT and OncoKB scales in liquid biopsy (LB) in advanced NSCLC patients (pts): Is it feasible and reliable?
2019-01-01 Mccusker, Mg; Russo, A; Chen, J; Scilla, Ka; Mehra, R; Rolfo, Cd.
Different metastatic pattern according to the EGFR mutational status in a cohort of lung adenocarcinomas (ADCs): a single-institution report.
2015-01-01 Russo, A; Franchina, T; Picone, A; Ferraro, G; Picciotto, M; Zanghì, M; Franchina, V; Adamo, V.
Challenges of interpreting NGS liquid biopsy (LB) results in advanced NSCLC: Are ESCAT and OncoKB scales reliable?
2019-01-01 Russo, A; Mccusker, M; Chen, J; Scilla, K; Mehra, R; Gittens, A; Rolfo, C.
Impact of erlotinib on overall survival in non small cell lung cancer patients: is the post progression survival a new paradigm?
2013-01-01 Franchina, Tindara; Russo, Alessandro; Proto, C; Chiofalo, G; Picciotto, Maria; Scimone, A; Toscano, G; Berenato, R; Noto, L; Adamo, Vincenzo
Activity of EGFR tyrosine kinase inhibitors (TKIs) in brain metastases from Non Small Cell Lung Cancer (NSCLC) according to the EGFR mutational status: a survival analysis.
2014-01-01 Picone, A; Franchina, T; Russo, A; Chiofalo, G; Scimone, A; Zanghì, M; Raiti, F; Agostino, Rm; Sava, S; Schifano, S; Silvestro, A; Smiroldo, V; Adamo, V.
Dynamic levels of extracellular vesicle PD-L1 and complementary radiomics for the prediction of the response to immune checkpoint inhibitors in lung cancer patients.
2021-01-01 Rolfo, Cd; De Miguel Perez, D; Russo, A; Murat, Ak; Gunasekaran, M; Manca, P; Peterson, Cb; Mamindla, P; Er, Me; Peddagangireddy, V; Buemi, F; Cooper, B; Hester, L; Hsia, Rc; Cardona, Af; Arrieta, O; Naing, A; Kaushal, S; Serrano, Mj; Colen, Rr.
Progression patterns after EGFR tyrosine kinase inhibitors (TKIs) in EGFR-mutated (EGFR-mut+) non small cell lung cancers (NSCLCs): Correlations with clinical oucomes.
2016-01-01 Russo, A; Smiroldo, V; Raiti, F; Franchina, T; Ferraro, G; Picciotto, M; Ricciardi, G; Scimone, A; Adamo, V.
Impact of EGFR tyrosine kinase inhibitors in the management of brain metastases from EGFR-mutated and wild-type (WT) non-small cell lung cancer (NSCLC): A survival analysis.
2014-01-01 Picone, A; Franchina, T; Russo, A; Proto, C; Raiti, F; Buda, C; Chiofalo, G; Ferraro, G; Picciotto, M; Scimone, A; Toscano, G; Zanghì, M; Adamo, V.
Can we better manage advanced NSCLC in the elderly with the new therapeutic agents? Preliminary analysis of a real life multicenter study
2017-01-01 Franchina, T; Novello, S; Russo, A; Gianetta, M; Capelletto, E; Galetta, D; Catino, A; Migliorino, Mr; Ricciardi, S; Morgillo, F; Della Corte, Cm; Rocco, D; Soto Parra, Hj; Russo, A; Ambrosio, F; Franchina, V; Adamo, V
Retrospective analysis of the therapeutic efficacy of platinum/etoposide schedules in the treatment of advanced poor differentiated neuroendocrine carcinomas of the lung.
2017-01-01 F., Chillari; G., Blanco; Russo, A; I, Puliafito; S., Munaò; A., Battaglia; T., Franchina; L., Castorina; D., Giuffrida; V., Adamo.
Treatment option for small cell lung cancer: does lanreotide represent a new choice?
2013-01-01 Franchina, Tindara; Proto, C; Russo, Alessandro; Chiofalo, G; Scimone, A; Adamo, Vincenzo
The evolving impact of genomic biomarker landscape in stage II colorectal cancer (CRC)
2020-01-01 Arrivi, G.; Marchetti, P.; Pilozzi, E.; Montori, A.; Balducci, G.; Mercantini, P.; Laghi, A.; Ierinò, D.; Panebianco, M.; Mazzuca, F.; Roberto, M.
Neonatal Outcomes of Newborns Exposed to SSRI during Pregancy: a Pharmacokinetic and Pharmacogenetic Analysis
2017-01-01 Corti, S.; Pileri, P.; Mandò, C.; Pogliani, L.; Clementi, E.; Cattaneo, D.; Cetin, I.
Measuring qualify of life in paients with relapsing-remitting MS (RRMS)
2016-01-01 Calabro', R. S.; Milardi, Demetrio; Cacciola, A; Marra, A.; Digangi, G; Casella, Carmela; Manuli, A.; De Luca, R.; Silvestri, Rosalia; Bramanti, Placido
High radiation dose delivery by lattice-rt to hypoxic areas in bulky tumours: a multicentric study
2022-01-01 Parisi, S; Ferini, G; Pontoriero, A; Viola, A; Cacciola, A; Lillo, S; Ferrantelli, G; Tamburella, C; Lo Giudice, G; Valenti, V; Tripoli, A; Chillari, F; Pergolizzi, S
Morbidity And Complication Of Minimally Invasive Staging For Apparent Early-Stage Epithelial Ovarian Cancer: A Preliminary Analysis Of REMISSION Study
2025-01-01 Giudici, Anna; Ghezzi, Fabio; Schivardi, Gabriella; Multinu, Francesco; Zanagnolo, Vanna; Bogani, Giorgio; Perrone, Anna Myriam; De Iaco, Pierandrea; Bizzarri, Niccolo'; Di Berardino, Stefano; Ricotta, Giulio; Martinelli, Fabio; Zapardiel, Ignacio; Raspagliesi, Francesco; Mueller, Michael D.; Ferron, Gwenael; Scambia, Giovanni; Lorusso, Domenica; Fagotti, Anna; Casarin, Jvan
Evaluating The Impact Of Carbon Ion Radiotherapy In Unresectable Female Genital Tract Melanomas: Insights From A Preliminary Real-World Study
2025-01-01 Barcellini, Amelia; Fontana, Giulia; Vai, Alessandro; Aletti, Giovanni Damiano; Charalampopoulou, Alexandra; Chiellino, Silvia; Ditto, Antonino; Landoni, Fabio; Locati, Laura Deborah; Mangili, Giorgia; Martinelli, Fabio; Piccolo, Federica; Franzetti, Jessica; Imparato, Sara; Brizzi, Leonardo; Raspagliesi, Francesco; Orlandi, Ester
omicsCNN: a general deep learning framework for omics data modeling and classification
2018-01-01 Jurman, Giuseppe; Maggio, Valerio; Landi, Isotta; Francescatto, Margherita; Chierici, Marco; De Domenico, Manlio; Furlanello, Cesare
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Association between baseline absolute neutrophil count (ANC), derived neutrophil-to-lymphocyte ratio (dNLR), and platelet-to-lymphocyte ratio (PLR) and response to nivolumab (Nivo) in non-small cell lung cancer (NSCLC): A preliminary analysis. | 1-gen-2017 | Russo, A; Scimone, A; Picciotto, M; Toscano, G; Raiti, F; Sava, S; Battaglia, A; Adamo, V. | |
| Epidermal Growth Factor Receptor mutational status predicts patterns of metastatic spread in treatment-naïve Adenocarcinomas of the lung. | 1-gen-2015 | Russo, A; Franchina, T; Picone, A; Raiti, F; Ricciardi, Grr; Franchina, V; Ferraro, G; Scimone, A; Toscano, G; Adamo, V. | |
| Application of ESCAT and OncoKB scales in liquid biopsy (LB) in advanced NSCLC patients (pts): Is it feasible and reliable? | 1-gen-2019 | Mccusker, Mg; Russo, A; Chen, J; Scilla, Ka; Mehra, R; Rolfo, Cd. | |
| Different metastatic pattern according to the EGFR mutational status in a cohort of lung adenocarcinomas (ADCs): a single-institution report. | 1-gen-2015 | Russo, A; Franchina, T; Picone, A; Ferraro, G; Picciotto, M; Zanghì, M; Franchina, V; Adamo, V. | |
| Challenges of interpreting NGS liquid biopsy (LB) results in advanced NSCLC: Are ESCAT and OncoKB scales reliable? | 1-gen-2019 | Russo, A; Mccusker, M; Chen, J; Scilla, K; Mehra, R; Gittens, A; Rolfo, C. | |
| Impact of erlotinib on overall survival in non small cell lung cancer patients: is the post progression survival a new paradigm? | 1-gen-2013 | Franchina, Tindara; Russo, Alessandro; Proto, C; Chiofalo, G; Picciotto, Maria; Scimone, A; Toscano, G; Berenato, R; Noto, L; Adamo, Vincenzo | |
| Activity of EGFR tyrosine kinase inhibitors (TKIs) in brain metastases from Non Small Cell Lung Cancer (NSCLC) according to the EGFR mutational status: a survival analysis. | 1-gen-2014 | Picone, A; Franchina, T; Russo, A; Chiofalo, G; Scimone, A; Zanghì, M; Raiti, F; Agostino, Rm; Sava, S; Schifano, S; Silvestro, A; Smiroldo, V; Adamo, V. | |
| Dynamic levels of extracellular vesicle PD-L1 and complementary radiomics for the prediction of the response to immune checkpoint inhibitors in lung cancer patients. | 1-gen-2021 | Rolfo, Cd; De Miguel Perez, D; Russo, A; Murat, Ak; Gunasekaran, M; Manca, P; Peterson, Cb; Mamindla, P; Er, Me; Peddagangireddy, V; Buemi, F; Cooper, B; Hester, L; Hsia, Rc; Cardona, Af; Arrieta, O; Naing, A; Kaushal, S; Serrano, Mj; Colen, Rr. | |
| Progression patterns after EGFR tyrosine kinase inhibitors (TKIs) in EGFR-mutated (EGFR-mut+) non small cell lung cancers (NSCLCs): Correlations with clinical oucomes. | 1-gen-2016 | Russo, A; Smiroldo, V; Raiti, F; Franchina, T; Ferraro, G; Picciotto, M; Ricciardi, G; Scimone, A; Adamo, V. | |
| Impact of EGFR tyrosine kinase inhibitors in the management of brain metastases from EGFR-mutated and wild-type (WT) non-small cell lung cancer (NSCLC): A survival analysis. | 1-gen-2014 | Picone, A; Franchina, T; Russo, A; Proto, C; Raiti, F; Buda, C; Chiofalo, G; Ferraro, G; Picciotto, M; Scimone, A; Toscano, G; Zanghì, M; Adamo, V. | |
| Can we better manage advanced NSCLC in the elderly with the new therapeutic agents? Preliminary analysis of a real life multicenter study | 1-gen-2017 | Franchina, T; Novello, S; Russo, A; Gianetta, M; Capelletto, E; Galetta, D; Catino, A; Migliorino, Mr; Ricciardi, S; Morgillo, F; Della Corte, Cm; Rocco, D; Soto Parra, Hj; Russo, A; Ambrosio, F; Franchina, V; Adamo, V | |
| Retrospective analysis of the therapeutic efficacy of platinum/etoposide schedules in the treatment of advanced poor differentiated neuroendocrine carcinomas of the lung. | 1-gen-2017 | F., Chillari; G., Blanco; Russo, A; I, Puliafito; S., Munaò; A., Battaglia; T., Franchina; L., Castorina; D., Giuffrida; V., Adamo. | |
| Treatment option for small cell lung cancer: does lanreotide represent a new choice? | 1-gen-2013 | Franchina, Tindara; Proto, C; Russo, Alessandro; Chiofalo, G; Scimone, A; Adamo, Vincenzo | |
| The evolving impact of genomic biomarker landscape in stage II colorectal cancer (CRC) | 1-gen-2020 | Arrivi, G.; Marchetti, P.; Pilozzi, E.; Montori, A.; Balducci, G.; Mercantini, P.; Laghi, A.; Ierinò, D.; Panebianco, M.; Mazzuca, F.; Roberto, M. | |
| Neonatal Outcomes of Newborns Exposed to SSRI during Pregancy: a Pharmacokinetic and Pharmacogenetic Analysis | 1-gen-2017 | Corti, S.; Pileri, P.; Mandò, C.; Pogliani, L.; Clementi, E.; Cattaneo, D.; Cetin, I. | |
| Measuring qualify of life in paients with relapsing-remitting MS (RRMS) | 1-gen-2016 | Calabro', R. S.; Milardi, Demetrio; Cacciola, A; Marra, A.; Digangi, G; Casella, Carmela; Manuli, A.; De Luca, R.; Silvestri, Rosalia; Bramanti, Placido | |
| High radiation dose delivery by lattice-rt to hypoxic areas in bulky tumours: a multicentric study | 1-gen-2022 | Parisi, S; Ferini, G; Pontoriero, A; Viola, A; Cacciola, A; Lillo, S; Ferrantelli, G; Tamburella, C; Lo Giudice, G; Valenti, V; Tripoli, A; Chillari, F; Pergolizzi, S | |
| Morbidity And Complication Of Minimally Invasive Staging For Apparent Early-Stage Epithelial Ovarian Cancer: A Preliminary Analysis Of REMISSION Study | 1-gen-2025 | Giudici, Anna; Ghezzi, Fabio; Schivardi, Gabriella; Multinu, Francesco; Zanagnolo, Vanna; Bogani, Giorgio; Perrone, Anna Myriam; De Iaco, Pierandrea; Bizzarri, Niccolo'; Di Berardino, Stefano; Ricotta, Giulio; Martinelli, Fabio; Zapardiel, Ignacio; Raspagliesi, Francesco; Mueller, Michael D.; Ferron, Gwenael; Scambia, Giovanni; Lorusso, Domenica; Fagotti, Anna; Casarin, Jvan | |
| Evaluating The Impact Of Carbon Ion Radiotherapy In Unresectable Female Genital Tract Melanomas: Insights From A Preliminary Real-World Study | 1-gen-2025 | Barcellini, Amelia; Fontana, Giulia; Vai, Alessandro; Aletti, Giovanni Damiano; Charalampopoulou, Alexandra; Chiellino, Silvia; Ditto, Antonino; Landoni, Fabio; Locati, Laura Deborah; Mangili, Giorgia; Martinelli, Fabio; Piccolo, Federica; Franzetti, Jessica; Imparato, Sara; Brizzi, Leonardo; Raspagliesi, Francesco; Orlandi, Ester | |
| omicsCNN: a general deep learning framework for omics data modeling and classification | 1-gen-2018 | Jurman, Giuseppe; Maggio, Valerio; Landi, Isotta; Francescatto, Margherita; Chierici, Marco; De Domenico, Manlio; Furlanello, Cesare |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista2015
Data di pubblicazione
- 2020 - 2025102
- 2010 - 20191267
- 2000 - 2009534
- 1990 - 1999111
- 1988 - 19891
Editore
- Nature Publishing Group4
- s.n4
- ICRS3
- Blackwell1
Rivista
- EUROPEAN UROLOGY. SUPPLEMENTS124
- GASTROENTEROLOGY121
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...119
- THE JOURNAL OF UROLOGY110
- DIGESTIVE AND LIVER DISEASE96
- THE JOURNAL OF NUCLEAR MEDICINE80
- ANNALS OF THE RHEUMATIC DISEASES69
- RADIOTHERAPY AND ONCOLOGY58
- ANNALS OF ONCOLOGY55
- JOURNAL OF CLINICAL ONCOLOGY44
Keyword
- Myelodysplastic syndrome8
- Survival4
- biomimetic3
- Mitochondrial ferritin3
- osteochondral3
- Prognosis3
- scaffold3
- Sideroblastic anemia3
- viscosupplementation3
- COLONOSCOPIC SURVEILLANCE2
Lingua
- eng732
- ita24
- und6
Accesso al fulltext
- no fulltext1962
- reserved51
- open2